Coastal Dermatology Symposium


September 22, 2022 – September 24, 2022




This activity is designed for dermatologists, internists, family physicians, physician assistants, nurse practitioners, nurses, and other health professionals interested in treating patients with dermatologic diseases.



[italic]After completing this live activity, participants should be better able to: [/italic] [bold]Acne and Rosacea [/bold] [LIST][ITEM]Discuss current theories on the pathophysiology of acne and rosacea as it relates to effective diagnosis and treatment targets. [ITEM]Formulate a comprehensive treatment plan for patients with acne or rosacea based on current clinical guidelines and incorporating advances in pharmacologic and non-pharmacologic therapies. [/LIST] [bold]Actinic Keratosis (AK) and Cutaneous Malignancies [/bold] [LIST][ITEM]Explain the similarities in the pathogenesis, histology, and clinical presentations of actinic keratosis and other forms of cutaneous malignancies in terms of potential targets for therapy. [ITEM]Identify and differentiate melanocytic from non-melanocytic lesions using dermoscopy. [ITEM]Summarize the lesion-directed and field-directed treatment options available for actinic keratoses. [ITEM]Discuss current and emerging therapies that hold promise for the effective treatment of skin cancers including actinic keratosis, basal cell carcinoma and melanoma. [ITEM]Describe uses of dermoscopy within and outside the discipline of cutaneous malignancy, including inflammatory disorders. [/LIST] [bold]Atopic Dermatitis [/bold] [LIST][ITEM]Examine emerging clinical and therapeutic science insights into the pathogenesis of atopic dermatitis, and associated comorbidities. [ITEM]Review the latest data on bathing, age indications for non-steroidal medications, and evolving indications for topical agents in atopic dermatitis. [ITEM]Explain clinical and therapeutic science insights in the effective management of atopic dermatitis including new modalities recently introduced into clinical practice. [/LIST] [bold]Hyperhidrosis [/bold] [LIST][ITEM]Identify the diagnostic criteria for focal and general hyperhidrosis. [ITEM]Evaluate the mechanisms of action and selection of therapeutic options for hyperhidrosis. [ITEM]Review the latest treatment options in the management of photosensitive and contact dermatitis. [/LIST] [bold]Photodermatoses and Contact Dermatitis [/bold] [LIST][ITEM]Describe the algorithm for the diagnosis of photodermatoses and contact dermatitis. [ITEM]Review the latest treatment options in the management of photosensitive and contact dermatitis. [/LIST] [bold]Psoriasis [/bold] [LIST][ITEM]Identify the psoriasis patient population that would benefit most from topical and systemic therapies including biologic response modifiers. [ITEM]Describe the pathophysiology of psoriasis and associated comorbidities of the disease. [ITEM]Identify key patient characteristics to individualize treatment selection in patients with psoriasis. [ITEM]Summarize current and emerging therapies in the management of moderate to severe patients with psoriasis. [ITEM]Formulate treatment plans for patients with skin disorders that reflect evidence-based guidelines and take patient-specific factors into consideration, such as age, race, and ethnicity. [/LIST]



[bold]Joint Accreditation Statement[/bold] [JALOGO] In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [bold]Physician Continuing Medical Education[/bold] The Postgraduate Institute for Medicine designates this live activity for a maximum of 13.75 [italic]AMA PRA Category 1 Credits™. [/italic]Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]Continuing Nursing Education [/bold] The maximum number of hours awarded for this Continuing Nursing Education activity is 13.75 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on certificates. [underline][italic]Disclosure of Conflicts of Interest [/italic][/underline] Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies.  All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.  The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.